Group 1: Core Insights - The Henan Provincial Academy of Medical Sciences is advancing cutting-edge medical technologies, focusing on clinical applications of innovative projects [3][5] - The academy has developed a new warm blood transport system for heart transplants, significantly extending the viability of hearts during transport [5][8] - The "organ-on-a-chip" technology is being utilized to personalize cancer treatment, allowing for the selection of the most effective therapies for patients [9][11] Group 2: Heart Transport System - The new transport system maintains a physiological temperature of 34°C to 36°C, avoiding the metabolic slowdown associated with traditional cold storage methods [5][7] - The system has shown promising results in animal experiments, with a pig heart remaining functional after 24 hours of transport [7][8] - Future experiments will simulate real-world transport conditions to further validate the system's effectiveness [7][8] Group 3: Organ-on-a-Chip Technology - The organ-on-a-chip platform has begun clinical validation, focusing on difficult-to-treat gynecological cancers [11][12] - The technology allows for the cultivation of "mini-tumors" from patient samples, which can be tested against various drug treatments to determine the most effective option [12][13] - Initial results indicate a 71% tumor suppression rate for one patient, showcasing the potential for improved treatment precision [12][13] Group 4: Nanomaterials and Agricultural Applications - The Henan Provincial Academy has launched the world's first pilot production line for nanoenzymes, marking a significant step towards industrialization [10][14] - The nanoenzyme technology has demonstrated the ability to enhance crop yields while reducing nitrogen fertilizer usage, with reported increases of up to 20.6% in certain crops [15][16] - The laboratory aims to expand the application of agricultural nanoenzymes across 20 million acres in Henan by 2026 [15][16]